Torrent leads race to acquire Cipla with 30% higher offer than Blackstone's

Shares of Cipla closed at Rs 1,239 apiece on the BSE on Monday, with a market valuation of Rs 1 trillion

Torrent Pharmaceuticals
Premium

A source close to Torrent said the group is in talks with several investors, including private equity firms, to join its bid to acquire Cipla – which is far bigger than Torrent in terms of revenues

Dev Chatterjee Mumbai

Listen to This Article

Torrent Pharmaceuticals has emerged as a frontrunner to acquire its rival Cipla with a non-binding offer that’s more than 30 per cent higher than American private equity giant Blackstone’s bid.
 
According to a source close to the negotiations, while Blackstone offered approximately Rs 900 a share, the Ahmedabad-based pharmaceutical firm has made an all-cash offer at around Rs 1,200 a share, which is close to the current market price of Cipla. Shares of Cipla closed at Rs 1,239 apiece on the BSE on Monday, with a market valuation of Rs 1 trillion.
 
The Hamied family, the promoter of Cipla, is expected to take a call on Torrent’s offer in two to three weeks, said the source. Spokespersons for Torrent Pharma

First Published: Sep 04 2023 | 7:02 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com